Coding for SLN procedures: 2019 changes for staff use | David O. Holtz, MD
Starting Jan. 1, 2019, there will be changes to the parenthetical statement under CPT code +38900 regarding the CPT codes that it can be billed with for intraoperative identification (e.g., mapping) of sentinel lymph nodes (SLN) for gynecologic malignancies and a new CPT code for biopsy of inguinofemoral nodes. These 2019 coding changes will affect how you bill for lymph node dissections. These changes are based on the work of the SGO Coding Taskforce and the American College of Obstetricians and Gynecologists (ACOG) Committee on Health Economics and Coding.
Previously, CPT code +38900 was restricted to procedures usually done for a diagnosis of breast cancer or melanoma and restricted from being billed with CPT codes for hysterectomies and vulvectomies. Given the acceptance of sentinel lymph node biopsy for vulvar cancer and endometrial cancer as seen in changes to the National Comprehensive Cancer Network (NCCN) guidelines over the past several years, this seemed like a good time to update the list of codes that CPT code +38900 could be billed with as supported by these NCCN guidelines.
Prior to Jan. 1, 2019, gynecologic oncologists would have to use one of the open or laparoscopic lymph node sampling codes by themselves to bill for a sentinel lymph node dissection for endometrial or vulvar cancer. These codes all pay approximately 3.0 work relative value units (wRVUs) less than lymphadenectomy procedures (see table below). The ability to bill for the injection of dye makes up for the difference in work and allows for the facility to bill for the dye.
A new code has also been added that allows us to properly bill for the work performed during a groin dissection for sentinel lymph node biopsy. CPT 38531 (biopsy or excision of lymph node(s); open, inguinofemoral node(s)) was created as an intermediate code between a simple open biopsy of the lymph node (CPT 38500) and more complex total lymph node dissections.
The new code CPT 38531 is intended to be used with the 38900 add on code, can be billed for just unilateral lymph nodes or used twice for bilateral lymph nodes. It can be billed at the time of a radical vulvectomy or as a subsequent separate procedure. This code cannot be billed with more extensive lymphadenectomy codes or any of the radical vulvectomy codes that already incorporate lymph node dissection (i.e. 38760, 38765, or 56631-56640).
The permission from CMS to use the add on injection code for sentinel lymph node identification (+38900) along with the additional inguinofemoral lymph node dissection code (38531) will allow us to continue to be compensated for work as we transition toward sentinel lymph nodes in gynecologic malignancies.
David O. Holtz, MD, is a gynecologic oncologist with Lankenau Hospital in Wynnewood, PA.
|CPT Code||Description||2019 wRVU|
|38570||Laparoscopy, surgical; with retroperitoneal lymph node sampling||8.49|
|+38900||Intraoperative identification (e.g., mapping) of sentinel lymph nodes||2.50 x 2(if bilateral)|
|38571||Laparoscopy, surgical; with bilateral total pelvic lymphadenectomy||12.00|
|56630||Vulvectomy, radical, partial||14.80|
|38531||Biopsy or excision of lymph nodes, inguinofemoral node||6.74|
|+38900||Intraoperative identification (e.g., mapping) of sentinel lymph nodes||2.50|
|56631||Vulvectomy, radical, partial; with unilateral inguinofemoral lymphadenectomy||18.99|
Disclaimer: SGO members and professional coders may seek coding advice and recommendations by submitting an email to firstname.lastname@example.org. Answers to incoming questions are provided by the members of the SGO Coding and Reimbursement Taskforce and represent their opinion based upon the current and usual practices in the field. Every effort is made to ensure the accuracy of the information provided. However, the information neither replaces information in Medicare regulations, the CPT-4 code book, or the ICD-9 CM code book; nor does it constitute legal advice. Responses to questions are intended only as a guide and are not a substitute for specific accounting or legal opinions. SGO expressly disclaims all responsibility and liability arising from use of, or reliance upon this information as a reference source, and assumes no responsibility or liability for any claims that may result directly or indirectly from use of this information, including, but not limited to, claims of Medicare or insurance fraud.